Cargando…

Spot the adenoma after pituitary apoplexy following a SARS-CoV-2 vaccination

Pituitary apoplexy often manifests with a severe headache and is often caused by bleeding in a pituitary adenoma, which is common and often undiagnosed. The pituitary gland is damaged when the tumour suddenly enlarges due to bleeding. Bleeding into the pituitary can block blood supply to the pituita...

Descripción completa

Detalles Bibliográficos
Autores principales: Finsterer, Josef, Scorza, Fulvio A., de Almeida, Antonio-Carlos G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Hemorrhagic Stroke Association. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575575/
https://www.ncbi.nlm.nih.gov/pubmed/36276782
http://dx.doi.org/10.1016/j.hest.2022.10.001
_version_ 1784811339667996672
author Finsterer, Josef
Scorza, Fulvio A.
de Almeida, Antonio-Carlos G.
author_facet Finsterer, Josef
Scorza, Fulvio A.
de Almeida, Antonio-Carlos G.
author_sort Finsterer, Josef
collection PubMed
description Pituitary apoplexy often manifests with a severe headache and is often caused by bleeding in a pituitary adenoma, which is common and often undiagnosed. The pituitary gland is damaged when the tumour suddenly enlarges due to bleeding. Bleeding into the pituitary can block blood supply to the pituitary gland. The larger the tumour, the higher the risk of a future pituitary apoplexy. Since only few cases have been reported, the SARS-CoV-2 vaccine is unlikely to cause pituitary apoplexy. Patients with new-type headache require neurological evaluation and may require cerebral imaging to rule out bleeding, ischemia, venous sinus thrombosis, meningitis, encephalitis, pituitary apoplexy, reversible cerebral vasoconstriction syndrome, dissection, or migraine.
format Online
Article
Text
id pubmed-9575575
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher International Hemorrhagic Stroke Association. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.
record_format MEDLINE/PubMed
spelling pubmed-95755752022-10-17 Spot the adenoma after pituitary apoplexy following a SARS-CoV-2 vaccination Finsterer, Josef Scorza, Fulvio A. de Almeida, Antonio-Carlos G. Brain Hemorrhages Article Pituitary apoplexy often manifests with a severe headache and is often caused by bleeding in a pituitary adenoma, which is common and often undiagnosed. The pituitary gland is damaged when the tumour suddenly enlarges due to bleeding. Bleeding into the pituitary can block blood supply to the pituitary gland. The larger the tumour, the higher the risk of a future pituitary apoplexy. Since only few cases have been reported, the SARS-CoV-2 vaccine is unlikely to cause pituitary apoplexy. Patients with new-type headache require neurological evaluation and may require cerebral imaging to rule out bleeding, ischemia, venous sinus thrombosis, meningitis, encephalitis, pituitary apoplexy, reversible cerebral vasoconstriction syndrome, dissection, or migraine. International Hemorrhagic Stroke Association. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd. 2022-10-17 /pmc/articles/PMC9575575/ /pubmed/36276782 http://dx.doi.org/10.1016/j.hest.2022.10.001 Text en © 2022 International Hemorrhagic Stroke Association Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Finsterer, Josef
Scorza, Fulvio A.
de Almeida, Antonio-Carlos G.
Spot the adenoma after pituitary apoplexy following a SARS-CoV-2 vaccination
title Spot the adenoma after pituitary apoplexy following a SARS-CoV-2 vaccination
title_full Spot the adenoma after pituitary apoplexy following a SARS-CoV-2 vaccination
title_fullStr Spot the adenoma after pituitary apoplexy following a SARS-CoV-2 vaccination
title_full_unstemmed Spot the adenoma after pituitary apoplexy following a SARS-CoV-2 vaccination
title_short Spot the adenoma after pituitary apoplexy following a SARS-CoV-2 vaccination
title_sort spot the adenoma after pituitary apoplexy following a sars-cov-2 vaccination
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575575/
https://www.ncbi.nlm.nih.gov/pubmed/36276782
http://dx.doi.org/10.1016/j.hest.2022.10.001
work_keys_str_mv AT finstererjosef spottheadenomaafterpituitaryapoplexyfollowingasarscov2vaccination
AT scorzafulvioa spottheadenomaafterpituitaryapoplexyfollowingasarscov2vaccination
AT dealmeidaantoniocarlosg spottheadenomaafterpituitaryapoplexyfollowingasarscov2vaccination